Current Medical Research and Opinion, Volume 34, Issue 6 (2018)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Current Medical Research and Opinion, Volume 34, Issue 6 (2018)

See all volumes and issues
Vol 40, 2024 Vol 39, 2023 Vol 38, 2022 Vol 37, 2021 Vol 36, 2020 Vol 35, 2019 Volume 34, 2018 Vol 33, 2017 Vol 32, 2016 Vol 31, 2015 Vol 30, 2014 Vol 29, 2013 Vol 28, 2012 Vol 27, 2011 Vol 26, 2010 Vol 25, 2009 Vol 24, 2008 Vol 23, 2007 Vol 22, 2006 Vol 21, 2005 Vol 20, 2004 Vol 19, 2003 Vol 18, 2002 Vol 17, 2001 Vol 16, 2000 Vol 15, 1999 Vol 14, 1997-1998 Vol 13, 1992-1997 Vol 12, 1990-1992 Vol 11, 1988-1990 Vol 10, 1986-1988 Vol 9, 1984-1985 Vol 8, 1982-1984 Vol 7, 1980-1982 Vol 6, 1979-1980 Vol 5, 1977-1979 Vol 4, 1976-1977 Vol 3, 1975-1976 Vol 2, 1974-1975 Vol 1, 1972-1973
Download citations Download PDFs Download issue

Diabetes

Cardiovascular

Article
A non-interventional comparative study of the 20:1 combination of cafedrine/theodrenaline versus ephedrine for the treatment of intra-operative arterial hypotension: the ‘HYPOTENS’ study design and rationale
Leopold Eberhart, Götz Geldner, Susanne Huljic, Kerstin Marggraf, Thomas Keller, Tilo Koch & Peter Kranke
Pages: 953-961
Published online: 28 Feb 2018
AbstractforA non-interventional comparative study of the 20:1 combination of cafedrine/theodrenaline versus ephedrine for the treatment of intra-operative arterial hypotension: the ‘HYPOTENS’ study design and rationale | Full Text | References | PDF (830.4 KB) | Supplemental
  • 373 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Different lymph node staging systems for patients with adenocarcinoma of esophagogastric junction
Zhangjian Zhou, Xin Xie, Nan Hao, Dongmei Diao, Yongchun Song, Peng Xia, Chengxue Dang & Hao Zhang
Pages: 963-970
Published online: 01 Feb 2018
AbstractforDifferent lymph node staging systems for patients with adenocarcinoma of esophagogastric junction | Full Text | References | PDF (1.2 MB)
  • 151 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The prevalence of hyperkalemia in the United States
Keith A. Betts, J. Michael Woolley, Fan Mu, Evangeline McDonald, Wenxi Tang & Eric Q. Wu
Pages: 971-978
Published online: 21 Feb 2018
AbstractforThe prevalence of hyperkalemia in the United States | Full Text | References | PDF (720.6 KB)
  • 1335 Views
  • 55 CrossRef citations
  • 0Altmetric
Letter
Calprotectin: a biomarker for both infant/childhood and adult disease
Re: Torun MT, Unver E, Yalcin Y, et al. The importance of calprotectin levels in obstructive sleep apnea syndrome severity. Curr Med Res Opin 2017: published online 18 October 2017, doi: 10.1080/03007995.2017.138390
Despina D Briana & Ariadne Malamitsi-Puchner
Page: 979
Published online: 16 Mar 2018
CitationforCalprotectin: a biomarker for both infant/childhood and adult disease | Full Text | References | PDF (128.3 KB)
  • 688 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Efficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period
Yutaka Seino, Takashi Sasaki, Atsushi Fukatsu, Hisae Imazeki, Hidekazu Ochiai & Soichi Sakai
Pages: 981-994
Published online: 20 Mar 2018
AbstractforEfficacy and safety of luseogliflozin added to insulin therapy in Japanese patients with type 2 diabetes: a multicenter, 52-week, clinical study with a 16-week, double-blind period and a 36-week, open-label period | Full Text | References | PDF (1.3 MB) | Supplemental
  • 3030 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access
Article
Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment
Reema Mody, Michael Grabner, Maria Yu, Ralph Turner, Anita Y. M. Kwan, Whitney York & Laura Fernández Landó
Pages: 995-1003
Published online: 04 Jan 2018
AbstractforReal-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment | Full Text | References | PDF (1.5 MB) | Supplemental
  • 5545 Views
  • 40 CrossRef citations
  • 0Altmetric
Free Access
Article
Incremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations
Anna D. Coutinho, Aditya D. Raju, Weijia Wang, Dana Stafkey-Mailey, Sharash Shetty & Stephen D. Sander
Pages: 1005-1012
Published online: 16 Feb 2018
AbstractforIncremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations | Full Text | References | PDF (941.2 KB)
  • 206 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands
Sofa D. Alfian, Pawida Worawutputtapong, Catharina C. M. Schuiling-Veninga, Jurjen van der Schans, Jens H. J. Bos, Eelko Hak & Petra Denig
Pages: 1013-1019
Published online: 15 Jan 2018
AbstractforPharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands | Full Text | References | PDF (855.9 KB) | Supplemental
  • 532 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
Concordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease
Huan Huang, Sharash Shetty, Elise Bauer & Kathleen Lang
Pages: 1021-1027
Published online: 10 Jan 2018
AbstractforConcordance with prescribing information dosage recommendations for dipeptidyl-peptidase-4 inhibitors among type 2 diabetes mellitus patients with moderate to severe chronic kidney disease | Full Text | References | PDF (726.9 KB)
  • 464 Views
  • 5 CrossRef citations
  • 0Altmetric
Review
Understanding concentrated insulins: a systematic review of randomized controlled trials
Fernando Ovalle, Alissa R. Segal, John E. Anderson, Michael R. Cohen, Tina M. Morwick & Jeffrey A. Jackson
Pages: 1029-1043
Published online: 10 Jan 2018
AbstractforUnderstanding concentrated insulins: a systematic review of randomized controlled trials | Full Text | References | PDF (1.2 MB) | Supplemental
  • 961 Views
  • 13 CrossRef citations
  • 0Altmetric
Article
Real-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data
Kathleen Lang, Hiep Nguyen, Huan Huang, Elise Bauer & Philip Levin
Pages: 1045-1051
Published online: 01 Mar 2018
AbstractforReal-world clinical responses in patients with type 2 diabetes mellitus adding exenatide BID (EBID) or mealtime insulin to basal insulin: a retrospective study using electronic medical record data | Full Text | References | PDF (821.7 KB)
  • 179 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Quality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec
Edurne Lecumberri, Maite Ortega, Marta Iturregui, José Antonio Quesada, Clotilde Vázquez & Domingo Orozco
Pages: 1053-1059
Published online: 15 Jan 2018
AbstractforQuality-of-life and treatment satisfaction in actual clinical practice of patients with Type 1 diabetes mellitus (T1DM) and hypoglycemia treated with insulin degludec | Full Text | References | PDF (587.7 KB)
  • 609 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Patient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database
Daniel C. Beachler, Gail Fernandes, Gaurav Deshpande, Jamileh Jemison, Jennifer G. Lyons, Stephan Lanes, Jinan Liu & Annie McNeill
Pages: 1061-1069
Published online: 05 Jan 2018
AbstractforPatient and prescriber characteristics among patients with type 2 diabetes mellitus continuing or discontinuing sulfonylureas following insulin initiation: data from a large commercial database | Full Text | References | PDF (906.6 KB)
  • 189 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Risk factors and direct medical cost of early versus late unplanned readmissions among diabetes patients at a tertiary hospital in Singapore
May Ee Png, Joanne Yoong, Cynthia Chen, Chuen Seng Tan, E. Shyong Tai, Eric Y. H. Khoo & Hwee Lin Wee
Pages: 1071-1080
Published online: 20 Feb 2018
AbstractforRisk factors and direct medical cost of early versus late unplanned readmissions among diabetes patients at a tertiary hospital in Singapore | Full Text | References | PDF (948.2 KB) | Supplemental
  • 425 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
The cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus
Sharash Shetty, Dana Stafkey-Mailey, Binglin Yue, Anna D. Coutinho, Weijia Wang, Angelo Del Parigi, Stephen D. Sander & Craig I. Coleman
Pages: 1081-1087
Published online: 29 Mar 2018
AbstractforThe cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus | Full Text | References | PDF (682.5 KB)
  • 385 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Retrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China
Xiaoning He, Lizheng Shi & Jing Wu
Pages: 1089-1098
Published online: 18 Jan 2018
AbstractforRetrospective database analysis of cancer risk in patients with type 2 diabetes mellitus in China | Full Text | References | PDF (4.1 MB) | Supplemental
  • 355 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida
Damon Tanton, Mei Sheng Duh, Marie-Hélène Lafeuille, Patrick Lefebvre, Dominic Pilon, Maryia Zhdanava, Bruno Emond, Doreen Inman & Robert A. Bailey
Pages: 1099-1115
Published online: 05 Mar 2018
AbstractforReal-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida | Full Text | References | PDF (2.4 MB)
  • 263 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Comparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan
Toshinari Asakura, Shuichi Suzuki, Toshihiko Aranishi & Zhihong Cai
Pages: 1117-1124
Published online: 12 Mar 2018
AbstractforComparative usability study of the dulaglutide single-use pen versus the insulin degludec FlexTouch® among self-injection-naïve patients with type 2 diabetes mellitus in Japan | Full Text | References | PDF (850.9 KB)
  • 3846 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access
Article
Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting
Carol H. Wysham, Dominic Pilon, Mike Ingham, Marie-Hélène Lafeuille, Bruno Emond, Rhiannon Kamstra, Michael Pfeifer & Patrick Lefebvre
Pages: 1125-1133
Published online: 27 Mar 2018
AbstractforQuality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting | Full Text | References | PDF (1.3 MB) | Supplemental
  • 537 Views
  • 8 CrossRef citations
  • 0Altmetric

Oncology

Article
Economic burden of treatment failure in chronic lymphocytic leukemia patients
Song Wang, Marie-Hélène Lafeuille, Patrick Lefebvre, Hela Romdhani, Bruno Emond & Mekré Senbetta
Pages: 1135-1142
Published online: 25 Apr 2018
AbstractforEconomic burden of treatment failure in chronic lymphocytic leukemia patients | Full Text | References | PDF (971.2 KB)
  • 459 Views
  • 4 CrossRef citations
  • 0Altmetric

Diabetes

Article
A real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin
Lawrence Blonde, Charmi Patel, Brahim Bookhart, Michael Pfeifer, Yen-Wen Chen & Bingcao Wu
Pages: 1143-1152
Published online: 20 Apr 2018
AbstractforA real-world analysis of glycemic control among patients with type 2 diabetes treated with canagliflozin versus dapagliflozin | Full Text | References | PDF (1.2 MB) | Supplemental
  • 894 Views
  • 9 CrossRef citations
  • 0Altmetric
Review
Strategies for implementing effective mealtime insulin therapy in type 2 diabetes
Mark Peyrot, Timothy S. Bailey, Belinda P. Childs & Gérard Reach
Pages: 1153-1162
Published online: 12 Mar 2018
AbstractforStrategies for implementing effective mealtime insulin therapy in type 2 diabetes | Full Text | References | PDF (819.1 KB)
  • 422 Views
  • 7 CrossRef citations
  • 0Altmetric

Publishing

Article Commentary
Substantial contribution and accountability: best authorship practices for medical writers in biomedical publications
Angela Stocks, Donna Simcoe, Dikran Toroser & Lisa DeTora
Pages: 1163-1168
Published online: 16 Apr 2018
AbstractforSubstantial contribution and accountability: best authorship practices for medical writers in biomedical publications | Full Text | References | PDF (528.9 KB)
  • 5173 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Explore articles